The relationship between the serum level of Vitamin D and vitiligo: A controlled study on 300 subjects

Journal of Cutaneous Medicine and Surgery

Volumn 20, Issue 2, 2016, Pages 139-145

  Khurrum, Huma ^a   AlGhamdi, Khalid M ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

25(OH)D; Autoimmunity; Depigmentation; Saudi Arabia; Vitamin D; Vitiligo

Indexed keywords

25 HYDROXYVITAMIN D; BIOLOGICAL MARKER; VITAMIN D;

ADULT; AGE DISTRIBUTION; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SEX DIFFERENCE; ULTRAVIOLET PHOTOTHERAPY; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITILIGO; ADOLESCENT; AUTOIMMUNITY; BLOOD; CONTROLLED CLINICAL TRIAL; DISEASE COURSE; IMMUNOLOGY; PREVALENCE; PROGNOSIS; SAUDI ARABIA; SEX RATIO; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AUTOIMMUNITY; BIOMARKERS; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; PREVALENCE; PROGNOSIS; SAUDI ARABIA; SEX DISTRIBUTION; VITAMIN D; VITILIGO; YOUNG ADULT;

EID: 84966389470     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.1177/1203475415610071     Document Type: Article

References (26)

1. El-Zawahry M. Pigmentary dermatoses. In: Skin Diseases in Arabian Countries. Cairo: French Institute of Oriental Archeology;1964: 55-72.
2. Lerner AB. On the etiology of vitiligo and gray hair. Am J Med. 1971;51:141-147.
3. Pierrot-Deseilligny C. Clinical implications of a possible role of vitamin D in multiple sclerosis. J Neurol. 2009;256(9):1468-1479.
4. Ben-Zvi I, Aranow C, Mackay M, et al. The impact of vitamin D on dendritic cell function in patients with systemic lupus erythematosus. PLoS One. 2010;5(2):e9193.
5. Zold E, Szodoray P, Gaal J, et al. Vitamin D deficiency in undifferentiated connective tissue disease. Arthritis Res Ther. 2008;10(5):R123.
6. Cutolo M, Otsa K, Uprus M, et al. Vitamin D in rheumatoid arthritis. Autoimmun Rev. 2007;7(1):59-64.
7. Nunes JP, Martins CS. Myocardial infarction, hypovitaminosis D and vitiligo. Rev Port Cardiol. 2010;29(5):839-840.
8. Silverberg JI, Silverberg AI, Malka E, et al. A pilot study assessing the role of 25 hydroxy vitamin D levels in patients with vitiligo vulgaris. J Am Acad Dermatol. 2010;62(6):937-941.
9. Cutillas-Marco E, Morales-Suárez-Varela MM, Marquina-Vila A, et al. Serum 25-hydroxyvitamin D levels in patients with cutaneous lupus erythematosus in a Mediterranean region. Lupus. 2010;19(7):810-814.
10. Uncu S, Yayli S, Bahadir S, et al. Relevance of autoimmune thyroiditis in children and adolescents with vitiligo. Int J Dermatol. 2011;50(2):175-179.
11. Zettinig G, Tanew A, Fischer G, et al. Autoimmune diseases in vitiligo: do anti-nuclear antibodies decrease thyroid volume? Clin Exp Immunol. 2003;131(2):347-354.
12. Kurtev A, Dourmishev AL. Thyroid function and autoimmunity in children and adolescents with vitiligo. J Eur Acad Dermatol Venereol. 2004;18(1):109-111.
13. Cantorna MT. Vitamin D and autoimmunity: is vitamin D status an environmental factor affecting autoimmune disease prevalence? Proc Soc Exp Biol Med. 2000;223:230-233.
14. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr. 2004;80:1678S-1688S.
15. Lemire J. 1,25-Dihydroxyvitamin D3-a hormone with immunomodulatory properties. Z Rheumatol. 2000;59: 24-27.
16. van Etten E, Mathieu C. Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol. 2005;97:93-101.
17. Klarquist J, Denman CJ, Hernandez C, et al. Reducing skin homing by functional Treg in vitiligo. Pigment Cell Melanoma Res. 2010;23(2):276-286.
18. Hossani-Madani AR, Halder RM. Topical treatment and combination approaches for vitiligo: new insights, new developments. G Ital Dermatol Venereol. 2010;145(1):57-78.
19. Birlea SA, Costin GE, Norris DA. Cellular and molecular mechanisms involved in the action of vitamin D analogs targeting vitiligo depigmentation. Curr Drug Targets. 2008;9(4): 345-359.
20. Alghamdi KM, Kumar A, Moussa NA. The role of vitamin D in melanogenesis with an emphasis on vitiligo. Indian J Dermatol Venereol Lepro. 2013;79(6):750-758.
21. Lotti T, Berti S, Moretti S. Vitiligo therapy. Expert Opin Pharmacother. 2009;10(17):2779-2785.
22. Birlea S, Birlea M, Cimponeriu D, et al. Autoimmune diseases and vitamin D receptor Apa-I polymorphism are associated with vitiligo in a small inbred Romanian community. Acta Derm Venereol. 2006;86(3):209-214.
23. Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 2008;87: 1080-1086.
24. Norval M, Wulf HC. Does chronic sunscreen use reduce vitamin D production to insufficient levels? Br J Dermatol. 2009;161:732-736.
25. Saleh HM, Abdel Fattah NS, Hamza HT. Evaluation of serum 25-hydroxyvitamin D levels in vitiligo patients with and without autoimmune diseases. Photodermatol Photoimmunol Photomed. 2013;29(1):34-40.
26. Xu X, Fu WW, Wu WY. Serum 25-hydroxyvitamin D deficiency in Chinese patients with vitiligo: a case-control study. PLoS One. 2012;7(12):e52778.